From gene expression and genotyping to copy number variation (CNV) analysis and viral titer, GENEWIZ Multiomics & Synthesis Solutions offer a versatile polymerase chain reaction (PCR) portfolio that can be tailored to support the needs of your genomics project. Whether through endpoint or real-time detection, our unmatched quantitative PCR (qPCR) or digital PCR (dPCR) capabilities provide you with precise, rapid quantitation of nucleic acid sequences to simplify and advance the path toward your next breakthrough. Reach out to our experts to discuss your specific needs for nucleic acid detection.
Regulatory guidelines recommend the use of PCR methodology for multiple quality and safety checkpoints throughout the drug development process. For cell and gene therapy products, hyper-sensitive dPCR has largely been used for the evaluation of viral titer as well as quantification of viral vector copy number (VCN) of treated cells for AAV, lentivirus, and retrovirus.
Contact us to learn how our customized PCR solutions can help you advance your clinical research.